The DiflucanŽ Partnership Programme
   
en Francais en français Contact
en Español en Español Print pagePrint page
Welcome Program Program DiflucanŽ About Axios Recent News Questions? DiflucanŽ Donation Application

New eligible countries are regularly included.
Please click here for the latest list

How do I apply ?
  If you wish to apply, please complete an application form by clicking here.



Diflucan® Partnership Program

Definition of Program Offer
Pfizer Inc makes available free of charge its antifungal medicine, Diflucan® (fluconazole), for the treatment of Cryptococcal meningitis and Esophageal candidiasis, two opportunistic infections associated with HIV/AIDS, to governmental and non-governmental organizations in more than 80 eligible countries in need. Countries with a greater than 1 percent HIV/AIDS prevalence will be given priority. The program has no time or dollar limit.

Diflucan® for donation is available in the following dosage forms: 200 mg tablets (pink in color), 200 mg intravenous vials, and 50 mg/5 ml powder for oral suspension for pediatric use.

The Diflucan Partnership Program also includes the training of health professionals in the diagnosis and treatment of opportunistic infections.

Pfizer

To Apply
Governments and non-governmental organizations interested in applying to receive DiflucanŽ should                click here to access the necessary documentation. Axios International, an international consultancy specialized in chronic disease management and drug delivery in developing countries, is managing the application process on behalf of Pfizer.

 

top
Welcome | About Pfizer | Program | Training | DiflucanŽ | About Axios | Links | Questions | Application

© 2000-2008 Axios.
  Privacy policy   updated on: Feb 3rd 2008